Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

Published:2020-04-02 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Qi Si-Min,Cheng Gang,Cheng Xiang-Dong,Xu Zhiyuan,Xu Beihua,Zhang Wei-Dong,Qin Jiang-Jiang

Funder

National Natural Science Foundation of China

Zhejiang Chinese Medical University

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference97 articles.

1. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.;Altun;Chem. Biol.,2011

2. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth.;An;Biochem. Pharmacol.,2017

3. mdm2 expression is induced by wild type p53 activity.;Barak;EMBO J.,1993

4. A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.;Becker;Cell Cycle,2008

5. Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.;Bhattacharya;Signal. Transd. Target Ther.,2018

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. MDM2 inhibitors in cancer immunotherapy: Current status and perspective;Genes & Diseases;2024-11

3. USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53;Frontiers in Oncology;2024-09-12

4. Deubiquitinating enzyme USP39 promotes the growth and metastasis of gastric cancer cells by modulating the degradation of RNA-binding protein RBM39;Journal of Biological Chemistry;2024-09

5. A molecular glue for P53;Medicine Plus;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3